Mankind Pharma IPO vs Tata Technologies IPO

Comparision between Mankind Pharma IPO and Tata Technologies IPO.

IPO Details

Mankind Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tata Technologies IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Mankind Pharma IPO	Tata Technologies IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Axis Capital Limited Iifl Securities Ltd Jefferies India Private Limited J.P. Morgan India Private Limited	Jm Financial Limited Citigroup Global Markets India Private Limited Bofa Securities India Limited
Registrar	Kfin Technologies Limited	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Tata Technologies IPO is up to ₹3,042.51 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Tata Technologies IPO is ₹500.00 per share.

	Mankind Pharma IPO	Tata Technologies IPO
Face Value	₹1 per share	₹2 per share
Issue Price (Lower)	₹1,026.00 per share	₹475.00 per share
Issue Price (Upper)	₹1,080.00 per share	₹500.00 per share
Issue Price (Final)	₹1,080.00 per share	₹500.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	13 shares	30 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size	4,00,58,844 shares	6,08,50,278 shares
OFS Issue Size (Amount)	up to ₹4,326.36 Cr	up to ₹3,042.51 Cr
Issue Size Total	4,00,58,844 shares	6,08,50,278 shares
Issue Size Total (Amount)	up to ₹4,326.36 Cr	up to ₹3,042.51 Cr

IPO Timetable

Mankind Pharma IPO opens on Apr 25, 2023, while Tata Technologies IPO opens on Nov 22, 2023. The closing date of Mankind Pharma IPO and Tata Technologies IPO is Apr 27, 2023, and Nov 24, 2023, respectively.

	Mankind Pharma IPO	Tata Technologies IPO
Anchor Bid Date	Apr 24, 2023	Nov 21, 2023
Issue Open	Apr 25, 2023	Nov 22, 2023
Issue Close	Apr 27, 2023	Nov 24, 2023
Basis Of Allotment (Tentative)	May 03, 2023	Nov 28, 2023
Initiation of Refunds (Tentative)	May 04, 2023	Nov 29, 2023
Credit of Share (Tentative)	May 05, 2023	Nov 29, 2023
Listing date (Tentative)	May 09, 2023	Nov 30, 2023
Anchor Lockin End date 1	Jun 02, 2023	Dec 28, 2023
Anchor Lockin End date 2	Aug 01, 2023	Feb 26, 2024

Financials

Mankind Pharma IPO P/E ratio is 32.5, as compared to Tata Technologies IPO P/E ratio of 32.53.

Mankind Pharma IPO

Tata Technologies IPO

Financial

Mankind Pharma Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	5,073.29	5,975.65	1,056.15	3,485.31	3,436.34	126.92
31-Mar-21	6,372.63	6,385.38	1,293.03	4,722.00	4,674.39	234.53
31-Dec-21	8,043.88	6,218.29	1,260.24	5,965.46	5,916.86	268.70
31-Mar-22	9,147.74	7,977.58	1,452.96	6,155.23	6,106.06	868.03
31-Dec-22	9,273.75	6,777.82	1,015.98	7,145.89	7,094.12	167.93
Amount in ₹ Crore

Tata Technologies Limited Financial Information (Restated Consolidated)

Tata Technologies Limited's revenue increased by 25.81% and profit after tax (PAT) rose by 42.8% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	30 Sep 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	5,142.42	5,201.49	4,218.00	3,572.74
Revenue	2,587.42	4,501.93	3,578.38	2,425.74
Profit After Tax	351.90	624.04	436.99	239.17
Net Worth	2,853.13	2,989.47	2,280.16	2,142.15
Reserves and Surplus	2,455.29	2,605.60	2,028.93	1,897.46
Total Borrowing
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

79.00%

66.79%

Promoter Shareholding (Post-Issue)

76.50%

55.39%

P/E Ratio

32.5

32.53

Market Cap

₹43263.60 Cr.

₹20283.43 Cr.

ROE

27.60%%

ROCE

26.10%%

Debt/Equity

EPS

₹33.20

₹15.37

RoNW

27.70%%

20.87%%

Shares Offered

In the Mankind Pharma IPO retail investors (RII) are offered 1,40,20,596 shares while in Tata Technologies IPO retail investors are offered 1,40,20,596 shares. Qualified institutional buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 1,05,47,382 shares in Tata Technologies IPO.

	Mankind Pharma IPO	Tata Technologies IPO
Anchor Investor Reserveration	1,20,17,652 shares	1,58,21,071 shares
Market Maker Reserveration
QIB	80,11,769 shares	1,05,47,382 shares
NII	60,08,827 shares	79,10,537 shares
RII	1,40,20,596 shares	1,84,57,919 shares
Employee	0 shares	20,28,342 shares
Others
Total	2,80,41,192 shares	4,50,29,207 shares

Bids Received (Subscription)

Mankind Pharma IPO subscribed 15.32x in total, whereas Tata Technologies IPO subscribed 69.43x.

	Mankind Pharma IPO	Tata Technologies IPO
QIB (times)	49.16x	203.41x
NII (times)	3.80x	62.11x
Big NII (times)	4.99x	70.67x
Small NII (times)	1.41x	44.98x
RII (times)	0.92x	16.50x
Employee (times)		3.70x
Other (times)		29.20x
Total (times)	15.32x	69.43x

Compare with others

Mankind Pharma IPO	Tata Technologies IPO
ideaForge Technology IPO	Senco Gold IPO
HMA Agro Industries IPO	Cyient DLM IPO
IKIO Lighting IPO	ideaForge Technology IPO
Tata Technologies IPO	HMA Agro Industries IPO
Nexus Select Trust REIT	IKIO Lighting IPO
Avalon Technologies IPO	Nexus Select Trust REIT
Udayshivakumar Infra IPO	Mankind Pharma IPO
Global Surfaces IPO	Avalon Technologies IPO
Divgi TorqTransfer Systems IPO	Udayshivakumar Infra IPO
Signatureglobal India IPO	Global Surfaces IPO

Comments

Add a public comment...